HCPLive staff

The approval, which was was supported by data from a 56-week trial involving 223 obese individuals 12-17 years old, recommended the capsules be used in conjunction with a reduced-calorie diet and increased physical activity.

The most recent protests to police brutality, and the ensuing violence across cities and towns, sparked response from most national medical institutions—who for decades have sought to address disparities in care.

The Abbott-developed test platform is already used as a molecular point-of-care device for influenza A and B, Strep A, and respiratory syncytial virus.

Younger patients display increased susceptibility to H1N1 relative to H3N2, according to study findings.

The Prometra II offers a pressure-driven, valve-gated delivery mechanism that allows for novel programming modes of intermittent flow followed by periods of no flow—a feature unique to this device.

Research from the University of California, San Diego School of Medicine and Veterans Affairs San Diego Healthcare System published online in the American Journal of Geriatric Psychiatry suggests that patients with post-traumatic stress disorder appear to be at risk for accelerated aging, or premature senescence.

University of Toronto researchers have found a novel role for a cell membrane-anchored mediator in cancer pain. They suggest that the serine protease TMPRSS2-a gene previously shown to play a key role in some of the most aggressive forms of androgen-fuelled cancers-appears to be the trigger behind the most severe forms of cancer pain.

Early diagnosis and treatment is the key to preventing long-term joint damage in patients with psoriatic arthritis.

Sitagliptin appears to have beneficial systemic and adipose anti-inflammatory effects in combination antiretroviral therapy-treated HIV-positive adults with impaired glucose tolerance. The drug may prevent cardiovascular problems by reducing inflammation linked to heart disease and stroke in this patient population.

The results of the largest study of its kind to date indicate that new antipsychotic medications-including quetiapine, olanzapine, and risperidone-do not appear to put women at additional risk of developing gestational diabetes, hypertensive disorders, or major blood clots that obstruct circulation, all conditions that often develop during pregnancy or with the use of older antipsychotic medications.

Click here to review the CME questions for this month's issue.

Click here to read the statement of need, learning objectives, instructions on how to obtain CME credit, faculty list and disclosures, and other information for this activity.

Erectile dysfunction (ED) may be a more common comorbidity than previously thought among patients with gout. Patients with gout may also be more likely to have severe ED.

Research shows febuxostat is more effective than allopurinol in reducing serum urate levels in patients with gout.

Research from Harvard Medical School and Boston University School of Medicine indicates that opioid dispensing and prescription opioid overdoses decreased substantially following two major changes in the pharmaceutical market in 2010: the introduction of abuse-deterrent, extended-release oxycodone hydrochloride and withdrawal of propoxyphene.

A survey of 571 US hospitals regarding practices used to prevent Clostridium difficile infection indicates that nearly half of the facilities appear to not be taking steps to prevent the infection that kills nearly 30,000 people and sickens hundreds of thousands more each year, despite strong evidence that these steps work.

Research indicates that acetaminophen appears to have a general blunting effect on patients' evaluative and emotional processing, regardless of negative or positive valence.

The first large study to compare mindfulness-based cognitive therapy (MBCT)-a psychological therapy designed to change the way people think and feel about their experiences-with maintenance antidepressant medication suggests that MBCT could offer an alternative to antidepressants for preventing depression relapse.

Fluticasone furoate/vilanterol (Breo Ellipta/GlaxoSmithKline and Theravance Inc) approved for the once-daily treatment of asthma in patients aged 18 years and older.

Patients in the SPIRIT-P1 trial with active psoriatic arthritis treated with ixekizumab achieved significant improvement as measured by ACR20 compared to patients who received placebo.

In contrast to recent studies linking patients who reside in higher elevations with increased rates of depression and suicide, a new study suggests that the prevalence of attention-deficit hyperactivity disorder appears to decrease as altitude increases.

The US Food and Drug Administration today announced it has approved Amgen's Corlanor (ivabradine) to reduce hospitalization from worsening heart failure.

The combination of nortriptyline and morphine appears to offer superior efficacy in providing relief from chronic neuropathic pain than monotherapy with either agent.

Results of a small study suggest that fecal microbiota transplantation appears to be more successful for treating Clostridium difficile infection than previously thought.

The rates of opioid misuse among US patients with chronic pain appear to average about 25%, according to the results of a recently published systematic review and data synthesis.

A large review of national data indicates that suicide rates for adolescents and young adults appear to be higher in rural communities than in urban communities, regardless of the method, a disparity that seems to be increasing over time.

A new poll from the National Sleep Foundation reveals that pain joins two related concerns -- stress and poor health -- as key correlates of shorter sleep duration and worse sleep quality.

A stepped-care intervention studied by researchers from the Richard L. Roudebush VA Medical Center in Indianapolis, the Regenstrief Institute and the Indiana University School of Medicine appears to statistically significantly improve pain-related disability among veterans of recent military operations.

Study results published in the March 10, 2015 issue of Nature Communications indicate that customizing a defense system used by bacteria and archaea to recognize HIV has brought researchers one step closer to creating a drug that could prevent HIV, treat patients already infected with HIV, and even remove dormant copies of the virus from patients with more advanced disease.

Critically ill patients with acute gouty arthritis who cannot be treated with standard therapy responded well to treatment with anakinra in a recent study.